National trends and outcomes for extra-corporeal membrane oxygenation use in high-risk pulmonary embolism

Ayman Elbadawi, 1 Department of Cardiovascular Medicine, University of Texas Medical Branch, Galveston, TX, USA.
Amgad Mentias, 2 Division of Cardiovascular Medicine, University of Iowa, Iowa City, IA, USA.
Islam Y. Elgendy, 3 Division of Cardiovascular Medicine, University of Florida, Gainesville, FL, USA.
Ahmed H. Mohamed, 4 Department of Internal Medicine, Rochester General Hospital, Rochester, NY, USA.
Mohammed Hz Syed, 4 Department of Internal Medicine, Rochester General Hospital, Rochester, NY, USA.
Gbolahan O. Ogunbayo, 5 Department of Cardiovascular Medicine, University of Kentucky, Lexington, KY, USA.
Odunayo Olorunfemi, 4 Department of Internal Medicine, Rochester General Hospital, Rochester, NY, USA.
Igor Gosev, 6 Division of Cardiac Surgery, University of Rochester Medical Center, Rochester, NY, USA.
Sunil Prasad, 6 Division of Cardiac Surgery, University of Rochester Medical Center, Rochester, NY, USA.
Scott J. Cameron, 6 Division of Cardiac Surgery, University of Rochester Medical Center, Rochester, NY, USA.

Abstract

Little is known about the temporal trends and outcomes for extra-corporeal membrane oxygenation (ECMO) in patients with high-risk pulmonary embolism (PE) in the United States. We queried the National Inpatient Sample (NIS) database from 2005 to 2013 to identify patients admitted with high-risk PE. Our objective was to determine trends for ECMO use in patients with high-risk PE. We also assessed in-hospital outcomes among patients with high-risk PE receiving ECMO. We evaluated 77,809 hospitalizations for high-risk PE. There was an upward trend in the utilization of ECMO from 0.07% in 2005 to 1.1% in 2013 ( p = 0.015). ECMO was utilized more in urban teaching hospitals and large hospitals. ECMO use was associated with lower mortality in patients with massive PE ( p < 0.001). In-hospital mortality for patients receiving ECMO was 61.6%, with no change over the observational period ( p = 0.68). Our investigation revealed several independent predictors of increased mortality in patients with high-risk PE using ECMO as hemodynamic support, including: age, female sex, obesity, congestive heart failure, and chronic pulmonary disease. ECMO, therefore, as a rescue strategy or bridge to definitive treatment, may be effective in the management of high-risk PE when selecting patients with favorable clinical characteristics.